Skip to content
PeptideAgent

Clinics in Nebraska

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

What Nebraska law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

Nebraska at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified clinics serving Nebraska

No verified clinics serving Nebraska are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Nebraska

Yes. A Nebraska resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a Nebraska-credentialed prescriber, including by telehealth, because Neb. Rev. Stat. section 38-1,143 lets any credential holder providing a telehealth service prescribe a drug they are otherwise authorized to prescribe. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy licensed in Nebraska; the Nebraska Board of Pharmacy works with the Department of Health and Human Services Licensure Unit, which issues pharmacy licenses, including mail service pharmacy licenses for out-of-state pharmacies shipping into Nebraska. [1] [2] [3] [4] [5] [6] [7] [8]

Compounded GLP-1 access in Nebraska

Nebraska patients using telehealth GLP-1 programs should confirm that the shipping pharmacy holds a Nebraska mail service pharmacy license in the DHHS license lookup. [7] [9]

Research use only sellers in Nebraska

The Nebraska Pharmacy Practice Act limits dispensing of prescription drugs to licensed pharmacies and practitioners, so sellers of "research use only" injectable peptides to Nebraska consumers are not lawful dispensers in the state. [4] [10]

How to check a clinic in Nebraska

  1. Confirm the prescribing clinician's license with the Nebraska medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the Nebraska Board of Pharmacy (licensing through the Department of Health and Human Services, Division of Public Health, Licensure Unit) license lookup. [1] [4] [5] [6] [7] [8]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Nebraska. [4] [10]

Common questions in Nebraska

Can I get a GLP-1 prescription in Nebraska through telehealth?

Yes. Neb. Rev. Stat. section 38-1,143 lets a Nebraska credential holder who is providing telehealth prescribe any drug they are authorized to prescribe, and semaglutide and tirzepatide are not controlled substances. [2]

All peptide legal questions for Nebraska

Sources

  1. [1]Nebraska DHHS Licensure Unit: pharmacist and Board of Pharmacy information
  2. [2]Neb. Rev. Stat. section 38-1,143, Telehealth; prescribing
  3. [3]Nebraska Telehealth Act, Neb. Rev. Stat. sections 71-8501 to 71-8508 (DHHS compilation)
  4. [4]Nebraska statutes relating to the Pharmacy Practice Act (DHHS compilation)
  5. [5]Neb. Rev. Stat. section 71-2407, Mail service pharmacy license; requirements; fee
  6. [6]Neb. Rev. Stat. section 38-2867.01, Authority to compound; standards; labeling; prohibited acts
  7. [7]Nebraska DHHS: mail service pharmacy initial license application
  8. [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  9. [9]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  10. [10]21 U.S.C. 331, Prohibited acts